Eutilex. (263050) Stock Overview

Eutilex.Co.,Ltd. discovers and develops immunomodulatory antibody therapeutics to treat cancers and autoimmune diseases. It develops anti-tumor T cell therapy and antibody therapeutics. The company was founded in 2015 and is headquartered in Seoul, South Korea.

263050 Stock Information

Symbol

263050

Address

Daeryung Technotown 17Seoul, 08594South Korea

Founded

Trading hours

Website

https://www.eutilex.com

Country

🇰🇷 South Korea

Phone Number

82 2 3402 7315

Eutilex. (263050) Price Chart

Eutilex. Overview: Key Details and Summary

Stock data	2025	Change
Price	$1.36	N/A
Market Cap	$9.94M	N/A
Shares Outstanding	7.29M	N/A
Employees	90.00	N/A